FDA Approves Inebilizumab to Treat Adult Patients With IgG4-RD
Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias
Study: Prevalence of Micronutrient Deficiencies in Patients With Type 2 Diabetes
Siremadlin Demonstrates Efficacy, Safety in Treatment of Patients With TP53 Wild-Type Chronic Lymphocytic Leukemia